
What is the First 100 Study?
Track the symptoms of Parkinson's with a study that
introduces holistic interventions and natural treatments
to restore health.
Describe the idea behind the First 100 Study.
Current treatments for Parkinson's have troublesome
side effects and are unable to address the underlying
causes of Parkinsons Disease. There has to be a better way.
Let's do a three year study to evaluate the effect of
holistic treatments. Anecdotal evidence reveals that
when people with Parkinson's Disease eat healthy food,
exercise, hydrate their cells, reduce stress, release
trauma and eliminate toxins, they feel better.
Let's :
- Acknowledge that the symptoms of Parkinson's
are caused
by a variety of interrelated factors.
- Assume that no single treatment or intervention
can "cure" Parkinson's.
- Expose holistic care to a study population of
100 persons for 3 years.
- Assert that the body has the wisdom to heal itself
when it is given proper nourishment and support.
- Do a pre-post study that meticulously tracks symptoms.
- Document the timing of recovery.
- Select holistic treatments that are inspired by the
experiences of people with Parkinson's who have
been able to get relief from their symptoms.
- Offer study subjects treatments that are specific
to their individual health needs.
- Break free of the constraints of an antiquated
scientific approach
that evaluates the effect of a
single treatment, holding "constant" everything else.
- Launch a revolutionary approach to scientific discovery.
The static research paradigm that is required to fund
research does not serve the needs of anyone who is
affected by the disease that is being studied.
I propose we do it differently. Hypothesis of the First 100
study: When treated holistically, persons with Parkinson's
will experience a significant relief from symptoms.
Some people who have had Parkinson's are symptom
free today. It was not easy. It was not quick, but it has been
possible for some people. Let's set out to examine whether
recovery is possible for anyone using a holistic approach.
What problem does this proposal address?
Relying on a conventional approach to scientific inquiry,
everyone with Parkinson's will be dead before any genuine
progress is made. Science is painfully slow and meticulous.
It is not intended or designed to help the living.
Conventional thinking in science evaluates the impact of a
single factor (like a drug or surgery). Parkinson's is clearly
a multi-faceted condition.
Evaluation of any one treatment is bound to have a miniscule
impact. This has in fact been the case with existing studies
of Parkinson's.
The First 100 study proposed here would never pass through
a university review process. No single factor is being evaluated
or "controlled."
There will never be an organization – government or private –
that has a vested interest in funding such a study. Who benefits
from the discovery that the body can heal itself other than the
patient? No one other than the patient.
If this idea becomes a reality, who would benefit the most
and why?
Persons with Parkinson's. Discoveries are reported in
real time, not years after the study is concluded. Information
about treatments that show promise are disseminated
through the internet. Anyone with Parkinson's anywhere in
the world can learn how they too can get relief from their
symptoms. Approaches that do not prove beneficial are
identified and disclosed, saving countless individuals
needless expense.
Researchers. Instead of being tied to the "slow as molasses"
approach to scientific discovery, researchers determine what
really makes a difference as the study project unfolds. There is a
limitless potential to identify the underlying causes of Parkinson's
and the treatments that can heal it.
Study volunteers and health care practitioners. First 100 study
volunteers who have Parkinson's receive the benefits from intensive
support and therapies offered by multi-disciplinary teams of health
care providers. Health care practitioners also learn which treatments
offer the most help to individuals with Parkinson's.
Describe the optimal outcome from the First 100 Study
Many people believe that Parkinson's is a progressively
degenerative disease. Once a person is diagnosed, this
long standing belief says that symptoms are destined to
deteriorate. The optimal outcome of the study will show that
this belief is blatantly false.
Quantitative and qualitative assessment instruments evaluate
the progress of each study subject. Standard research
instruments from the Parkinson's literature are administered
before the treatments begin. Qualitative assessments include
extensive interviews and videos of motor functions. All pre-test
symptoms are thoroughly and systematically recorded.
Using the same quantitative and qualitative instruments,
follow-up evaluations are administered periodically over the
course of the three year study. Every aspect of the individual's
condition is tracked.
Research on Parkinson's provides extensive baseline evidence
on the "natural" progression of symptoms. Meta-analytic
techniques are used to derive estimates for the disease
progression of people with Parkinson's who do not receive
the benefits of a holistic intervention.
First Step
I am currently recruiting a researcher to develop a full fledged
proposal for the first 100 Study. Once I locate the appropriate
person, I will solicit tax deductible contributions to fund the
proposal development process.
The First 100 Study will be
underwritten by the support of individuals interested in finding
the answers for Parkinson's.
. |